COVID-19 mitigation behaviors and policies limited SARS-CoV-2 transmission in the United States from September 2020 through November 2021
View ORCID ProfileVelma K. Lopez, Sarah Kada, Pragati V. Prasad, Taylor Chin, Betsy L. Cadwell, Jessica M. Healy, Rachel B. Slayton, Matthew Biggerstaff, Michael A. Johansson
doi: https://doi.org/10.1101/2023.07.19.23292882
Velma K. Lopez
1National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector Borne Diseases, Centers for Disease Control and Prevention (CDC)
Sarah Kada
1National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector Borne Diseases, Centers for Disease Control and Prevention (CDC)
Pragati V. Prasad
2National Center for Immunization and Respiratory Diseases, Influenza Division, CDC
Taylor Chin
1National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector Borne Diseases, Centers for Disease Control and Prevention (CDC)
Betsy L. Cadwell
3Global Health Center, Division Global Health Protection, CDC
Jessica M. Healy
4NCEZID, Division of Healthcare Quality Promotion, CDC
Rachel B. Slayton
4NCEZID, Division of Healthcare Quality Promotion, CDC
Matthew Biggerstaff
2National Center for Immunization and Respiratory Diseases, Influenza Division, CDC
Michael A. Johansson
1National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector Borne Diseases, Centers for Disease Control and Prevention (CDC)
Posted July 23, 2023.
COVID-19 mitigation behaviors and policies limited SARS-CoV-2 transmission in the United States from September 2020 through November 2021
Velma K. Lopez, Sarah Kada, Pragati V. Prasad, Taylor Chin, Betsy L. Cadwell, Jessica M. Healy, Rachel B. Slayton, Matthew Biggerstaff, Michael A. Johansson
medRxiv 2023.07.19.23292882; doi: https://doi.org/10.1101/2023.07.19.23292882
COVID-19 mitigation behaviors and policies limited SARS-CoV-2 transmission in the United States from September 2020 through November 2021
Velma K. Lopez, Sarah Kada, Pragati V. Prasad, Taylor Chin, Betsy L. Cadwell, Jessica M. Healy, Rachel B. Slayton, Matthew Biggerstaff, Michael A. Johansson
medRxiv 2023.07.19.23292882; doi: https://doi.org/10.1101/2023.07.19.23292882
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (716)
- Anesthesia (210)
- Cardiovascular Medicine (2992)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12881)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4677)
- Geriatric Medicine (428)
- Health Economics (737)
- Health Informatics (2974)
- Health Policy (1079)
- Hematology (396)
- HIV/AIDS (942)
- Medical Education (434)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4457)
- Nursing (239)
- Nutrition (654)
- Oncology (2319)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1208)
- Primary Care Research (506)
- Public and Global Health (7055)
- Radiology and Imaging (1565)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (60)
- Transplantation (214)
- Urology (186)